220 related articles for article (PubMed ID: 25326851)
1. Clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy?
Gatto F; Grasso LF; Nazzari E; Cuny T; Anania P; Di Somma C; Colao A; Zona G; Weryha G; Pivonello R; Ferone D
Pituitary; 2015 Oct; 18(5):583-91. PubMed ID: 25326851
[TBL] [Abstract][Full Text] [Related]
2. ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases.
De Herdt C; Philipse E; De Block C
Eur J Endocrinol; 2021 Jul; 185(2):R65-R74. PubMed ID: 34132199
[TBL] [Abstract][Full Text] [Related]
3. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
Rimareix F; Grunenwald S; Vezzosi D; Rivière LD; Bennet A; Caron P
Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
[TBL] [Abstract][Full Text] [Related]
4. Is the incidence of differentiated thyroid cancer increased in patients with thyrotropin-secreting adenomas? Report of three cases from a large consecutive series.
Perticone F; Pigliaru F; Mariotti S; Deiana L; Furlani L; Mortini P; Losa M
Thyroid; 2015 Apr; 25(4):417-24. PubMed ID: 25647054
[TBL] [Abstract][Full Text] [Related]
5. Diagnosing Thyrotropin-Secreting Pituitary Adenomas by Short-Term Somatostatin Analogue Test.
Han R; Shen L; Zhang J; Xie J; Fang W; Sun Q; Bian L; Zhou Y; Wang S; Ning G; Wang W; Ye L
Thyroid; 2020 Sep; 30(9):1236-1244. PubMed ID: 32212919
[No Abstract] [Full Text] [Related]
6. Diagnosis, pathology, and management of TSH-secreting pituitary tumors. A single-center retrospective study of 20 patients from 1981 to 2014.
Căpraru OM; Gaillard C; Vasiljevic A; Lasolle H; Borson-Chazot F; Raverot V; Jouanneau E; Trouillas J; Raverot G
Ann Endocrinol (Paris); 2019 Sep; 80(4):216-224. PubMed ID: 31400861
[TBL] [Abstract][Full Text] [Related]
7. A long-term follow-up study of eighteen patients with thyrotrophin-secreting pituitary adenomas.
van Varsseveld NC; Bisschop PH; Biermasz NR; Pereira AM; Fliers E; Drent ML
Clin Endocrinol (Oxf); 2014 Mar; 80(3):395-402. PubMed ID: 23848527
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
9. Clinical aspects and therapeutic outcome in thyrotropin-secreting pituitary adenomas: a single center experience.
Macchia E; Gasperi M; Lombardi M; Morselli L; Pinchera A; Acerbi G; Rossi G; Martino E
J Endocrinol Invest; 2009 Oct; 32(9):773-9. PubMed ID: 19636221
[TBL] [Abstract][Full Text] [Related]
10. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.
Socin HV; Chanson P; Delemer B; Tabarin A; Rohmer V; Mockel J; Stevenaert A; Beckers A
Eur J Endocrinol; 2003 Apr; 148(4):433-42. PubMed ID: 12656664
[TBL] [Abstract][Full Text] [Related]
11. Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: Treatment outcome and long-term remission at a single pituitary center.
Liu J; Yang Y; Duan L; Chai X; Zhu H; Deng K; Lian X; Yao Y
Front Endocrinol (Lausanne); 2022; 13():1061029. PubMed ID: 36518240
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide.
Kuhn JM; Arlot S; Lefebvre H; Caron P; Cortet-Rudelli C; Archambaud F; Chanson P; Tabarin A; Goth MI; Blumberg J; Catus F; Ispas S; Beck-Peccoz P
J Clin Endocrinol Metab; 2000 Apr; 85(4):1487-91. PubMed ID: 10770186
[TBL] [Abstract][Full Text] [Related]
13. An audit of treatment outcome in acromegalic patients attending our center at Bergamo, Italy.
Attanasio R; Montini M; Valota M; Cortesi L; Barbò R; Biroli F; Tonnarelli G; Albizzi M; Testa RM; Pagani G
Pituitary; 2008; 11(1):1-11. PubMed ID: 17690987
[TBL] [Abstract][Full Text] [Related]
14. Thyrotropin-secreting pituitary adenomas: diagnosis and management of patients from one Chinese center.
Zhao W; Ye H; Li Y; Zhou L; Lu B; Zhang S; Wen J; Li S; Yang Y; Hu R
Wien Klin Wochenschr; 2012 Oct; 124(19-20):678-84. PubMed ID: 23053568
[TBL] [Abstract][Full Text] [Related]
15. [Thyrotropin-secreting pituitary adenomas: clinical features and results of treatment in 45 patients].
Trukhina DA; Przhiyalkovskaya EG; Belaya ZE; Grigoriev AY; Azizyan VN; Mamedova EO; Rozhinskaya LY; Lapshina AM; Pigarova EA; Dzeranova LK; Platonova NM; Troshina EA; Melnichenko GA
Probl Endokrinol (Mosk); 2023 Sep; 70(2):23-36. PubMed ID: 38796758
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment and outcome of TSH-producing pituitary adenomas.
Rotermund R; Riedel N; Burkhardt T; Matschke J; Schmidt NO; Aberle J; Flitsch J
Acta Neurochir (Wien); 2017 Jul; 159(7):1219-1226. PubMed ID: 28204898
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
18. Pituitary macroadenoma secreting thyrotropin and growth hormone: remission of bihormonal hypersecretion in response to lanreotide therapy.
Shimon I; Nass D; Gross DJ
Pituitary; 2001 Sep; 4(4):265-9. PubMed ID: 12501978
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of pituitary adenomas].
Mezosi E; Nemes O
Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
[TBL] [Abstract][Full Text] [Related]
20. Long term treatment of a thyrotropin-secreting microadenoma with somatostatin analogues.
Prieto-Tenreiro A; Díaz-Guardiola P
Arq Bras Endocrinol Metabol; 2010; 54(5):502-6. PubMed ID: 20694413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]